ielrifi@cooley.com
Dr. Ivor Elrifi is the chair of Cooley's global patent counseling and prosecution practice group. He advises pharmaceutical, biotechnology, life sciences and medical device companies, research institutions, universities, hospitals and governments throughout the world, particularly in the US and Europe. His practice includes patent prosecution, litigation, arbitration, licensing and transactional work with a focus on novel therapeutic treatments, biotechnology, genetics, diagnostics, biomarkers, drug formulations and medical devices.
Download full bio
Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II
Flexion Therapeutics Agrees to Sell to Pacira BioSciences
Exscientia – $510.4 Million IPO
Ovid - $75 Million IPO
Reata Pharmaceuticals – $505 Million Follow-On Offering
View all
Intellectual Property
Patent Counseling & Prosecution – Life Sciences
Patent Office Litigation
Life Sciences IP Litigation
Life Sciences
Medtech
Israel
Patent Strategy & Management Attorney of the Year
Osgoode Hall Law School, York UniversityJD, 1989
Queen's University at KingstonPhD, Biology, 1986
Queen's University at KingstonBS, Biology1982
California
Massachusetts
New York
Ontario, Canada
U.S. Patent and Trademark Office
Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II December 9, 2021
Exscientia – $510.4 Million IPO October 5, 2021
Cooley Shortlisted Across Five Categories for LMG Life Sciences Americas Awards August 9, 2021
Chambers: Leading Patent and Life Sciences Lawyer
Euromoney: Global Leader in Patent Law
Fellows of the American Bar Foundation: Elected Member
IAM Patent 1000: Leading Patent Lawyer
Legal 500: Leading Lawyer for Patent Prosecution and Healthcare
LMG Life Sciences: "Patent Strategy and Management Attorney of the Year" and Life Sciences Star
Managing Intellectual Property: IP Star
Super Lawyers: Top IP Lawyer
+1 212 479 6840
Locations